Company news
Hemogenyx Pharmaceuticals Plc (LSE:HEMO) news
Hemogenyx Pharmaceuticals Plc news releases on 6ix. Latest, Jun 4, 2020: Result of AGM and Completion of Placing
Press releases — page 4
Result of AGM and Completion of Placing
June 4, 2020
CDX Development Agreement Extension
June 2, 2020
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
May 27, 2020
Exercise of Warrants
May 18, 2020
Conditional Placing to raise £2,500,000
May 12, 2020
COVID-19 Project Initiated
April 22, 2020
Approval and Issuance of European Hu-PHEC Patent
April 21, 2020
HEMO-CAR-T cells Effective Against AML in vivo
February 20, 2020
Approval and Issuance of U.S. Hu-PHEC Patent
February 11, 2020
Placing and Subscription to raise £650,000
January 30, 2020
HEMO's CAR-T Cells Effective Against AML in vitro
January 15, 2020
Operational Update
November 18, 2019
Presentation at the Investival Showcase
November 12, 2019
Presentation at the NY Oncology Investor Conf.
November 6, 2019
Research Agreement with Global Pharma Company
October 23, 2019
Presentation at NY Stem Cell Foundation conference
October 21, 2019
Hemogenyx scientific advisor receives Lasker Award
September 12, 2019
CDX Patent Application
July 12, 2019
Development of ApbHC
June 24, 2019
CDX Effective as Conditioning Therapeutic in vivo
June 12, 2019
CDX Antibody is Effective against AML in vivo
June 5, 2019
CDX Antibody is Effective against ALL in vitro
May 30, 2019
Posting of Annual Report and Notice of AGM
May 28, 2019
Variation of Terms of Warrant Instrument
May 15, 2019
Final Results for the Year Ended 31 December 2018
April 29, 2019
Presentation at Cancer Immunotherapy Conference
January 30, 2019
Directorate Change
December 20, 2018
Directorate Change & Appointment
November 5, 2018
Orgenesis collaboration for Hu-PHEC development
October 22, 2018
Collaboration, License and Investment by Orgenesis
October 19, 2018
Collaboration with Johnson & Johnson Innovation
October 15, 2018
Change of Adviser
September 28, 2018
Hemogenyx to present at Oxford conference
September 3, 2018
Investor presentation
June 8, 2018
Development Agreement
May 14, 2018
Research Collaboration with Rockefeller University
May 8, 2018
Collaboration with major US biotechnology company
March 13, 2018
Advisory Board Appointment
March 6, 2018
Align Research Initiation of Coverage
March 1, 2018
Stmnt re Share Price Movement
February 26, 2018
Hemogenyx Welcomes N.Y. Lt. Governor to its Labs
January 11, 2018
AGM Statement
December 7, 2017
University of Oxford Collaboration
November 20, 2017
Notice of AGM
November 14, 2017
Statement re Press Comment
November 13, 2017
LakePharma appointed for lead product development
October 30, 2017
Cornell University update
October 5, 2017
Investor presentations
September 26, 2017
Proposed acquisition and Placing & Subscription
September 11, 2017
Proposed acquisition of Lime Holdings Limited
September 30, 2016